Drug target prediction using adverse event report systems: A pharmacogenomic approach

Bioinformatics

Volumn 28, Issue 18, 2012, Pages

  Takarabe, Masataka ^a   Kotera, Masaaki ^a   Nishimura, Yosuke ^a   Goto, Susumu ^a   Yamanishi, Yoshihiro ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; PROTEIN;

ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; EVALUATION; FOOD AND DRUG ADMINISTRATION; GENETICS; GENOMICS; HUMAN; METHODOLOGY; PHARMACOGENETICS; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; GENOMICS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PROTEINS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84866446560     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts413     Document Type: Article

References (21)

1. Atias,N. and Sharan,R. (2011) An algorithmic framework for predicting side-effects of drugs. J. Comput. Biol., 18, 207-218.
2. Blagg,J. (2006) Structure-activity relationships for in vitro and in vivo toxicity. Annu. Rep. Med. Chem., 41, 353-368.
3. Bleakley,K. and Yamanishi,Y. (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics, 25, 2397-2403.
4. Campillos,M. et al. (2008) Drug target identification using side-effect similarity. Science, 321, 263-266.
5. Dobson,C. (2004) Chemical space and biology. Nature, 432, 824-828.
6. Faulon,J. et al. (2008) Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor. Bioinformatics, 24, 225-233.
7. Jacob,L. and Vert,J.-P. (2008) Protein-ligand interaction prediction: an improved chemogenomics approach. Bioinformatics, 24, 2149-2156.
8. Kanehisa,M. et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res., 36(Database issue), D480-D485.
9. Kanehisa,M. et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 34(Database issue), D354-357.
10. Keiser,M. et al. (2009) Predicting new molecular targets for known drugs. Nature, 462, 175-81.
11. Kuhn,M. et al. (2010) A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol., 6, 343.
12. Mahe,P. et al. (2005) Graph kernels for molecular structure-activity relationship analysis with support vector machines. J. Chem. Inf. Model., 45, 939-951.
13. Saigo,H. et al. (2004) Protein homology detection using string alignment kernels. Bioinformatics, 20, 1682-1689.
14. Sakaeda,T. et al. (2011) Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations. Int. J. Med. Sci., 8, 487-491.
15. Stockwell,B. (2000) Chemical genetics: ligand-based discovery of gene function. Nat. Rev. Genet., 1, 116-125.
16. Tatonetti,N. et al. (2011) Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin. Pharmacol. Ther., 90, 133-142.
17. Tatonetti,N. et al. (2012) A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. J. Am. Med. Inform. Assoc., 19, 79-85.
18. van Laarhoven,T. et al. (2011) Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics, 27, 3036-3043.
19. Whitebread,S. et al. (2005) Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discov. Today, 10, 1421-1433.
20. Yamanishi,Y. et al. (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 24, i232-i240.
21. Yamanishi,Y. et al. (2010) Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics, 26, i246-i254.